vimarsana.com
Home
Live Updates
Coya Therapeutics Licenses Intellectual Property Rights for
Coya Therapeutics Licenses Intellectual Property Rights for
Coya Therapeutics Licenses Intellectual Property Rights for Use of Next Generation Immune Modulatory Biologics in Combination with COYA 301 to Enhance Regulatory T Cells (Tregs) in Inflammatory Diseases
License from University of Nebraska Medical Center covers multiple low dose interleukin-2 combinations, including ld IL-2 + Granulocyte-Macrophage Colony Stimulating Factor ;
New data, viewable...
Related Keywords
Texas ,
United States ,
Nebraska ,
Houston ,
University Of Nebraska Medical Center ,
Michael Dixon ,
Stanley Appel ,
David Beers ,
Jason Thonhoff ,
National Institutes Of Health ,
Unemed Corporation ,
Nasdaq ,
Coya Therapeutics Inc ,
Houston Methodist Research Institute ,
Coya Therapeutics ,
Dmed Corporation ,
Technology Transfer Office ,
Nebraska Medical Center ,
Chief Business ,
Nebraska Medical ,
About Amyotrophic Lateral ,
Lou Gehrig ,
Markets ,